ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 109 filers reported holding ENZO BIOCHEM INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,609,000 | +33.6% | 1,528,737 | -2.0% | 0.00% | +100.0% |
| Q3 2016 | $7,942,000 | -18.3% | 1,560,324 | -4.2% | 0.00% | -50.0% |
| Q2 2016 | $9,723,000 | +62.7% | 1,628,583 | +24.0% | 0.00% | +100.0% |
| Q1 2016 | $5,976,000 | +6.7% | 1,313,472 | +5.5% | 0.00% | 0.0% |
| Q4 2015 | $5,602,000 | +40.4% | 1,244,816 | -1.1% | 0.00% | 0.0% |
| Q3 2015 | $3,990,000 | +5.3% | 1,258,723 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $3,788,000 | -16.0% | 1,250,007 | -18.3% | 0.00% | 0.0% |
| Q1 2015 | $4,512,000 | -31.0% | 1,529,448 | +3.9% | 0.00% | 0.0% |
| Q4 2014 | $6,538,000 | -12.9% | 1,472,443 | +1.1% | 0.00% | 0.0% |
| Q3 2014 | $7,504,000 | +1.4% | 1,457,071 | +3.4% | 0.00% | 0.0% |
| Q2 2014 | $7,400,000 | +62.2% | 1,409,537 | +28.5% | 0.00% | 0.0% |
| Q1 2014 | $4,563,000 | +77.1% | 1,096,938 | +24.3% | 0.00% | – |
| Q4 2013 | $2,576,000 | +30.1% | 882,157 | +12.3% | 0.00% | – |
| Q3 2013 | $1,980,000 | +9.8% | 785,595 | -9.4% | 0.00% | – |
| Q2 2013 | $1,803,000 | – | 866,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |